2019

CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Prognosis in Patients With Breast Cancer.

He W, Grassmann F, Eriksson M, Eliasson E, Margolin S, Thorén L, Hall P, Czene K. J Clin Oncol. 2019 Dec 4:JCO1901535. doi: 10.1200/JCO.19.01535.

https://pubmed.ncbi.nlm.nih.gov/31800347